BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Dec 13, 2010
 |  BC Week In Review  |  Company News  |  Deals

Angiochem, Geron deal

Angiochem granted Geron exclusive, worldwide rights to receptor-targeting peptides conjugated to tubulin disassembly inhibitors. The deal includes GRN1005 (formerly ANG1005), which is slated to begin...

Read the full 132 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >